A Phase III Open-Label, Multicentre Trial of Maintenance Therapy with Avelumab (MSB0010718C) Versus Continuation of First-Line Chemotherapy in Subjects with Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of Stomach, or of the Gastro-Esophageal Junction

  • Strickland, Andrew (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

Effective start/end date18/10/1917/10/24


  • clinical trial
  • treatment efficacy
  • phase 3 study
  • stomach cancer
  • gastro-oesophageal cancer